Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$944K Sell
7,854
-250
-3% -$28.9K 0.57% 31
2025
Q4
$853K Sell
8,104
-1,210
-13% -$114K 0.5% 35
2025
Q3
$782K Hold
9,314
0.46% 34
2025
Q2
$737K Sell
9,314
-350
-4% -$27.8K 0.48% 34
2025
Q1
$867K Sell
9,664
-75
-0.8% -$7K 0.58% 33
2024
Q4
$969K Buy
+9,739
New +$1M 0.65% 30

Other funds holding MRK

Ames National Corp's MRK Position: Q1 2026 in Review

Ames National Corp reduced its Merck (MRK) stake by 3.1% in Q1 2026, selling an estimated $28.9K and leaving 7,854 shares worth $944K. The position accounts for 0.57% of the portfolio, ranked #31.

Ames National Corp first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $969K in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ames National Corp held 7,854 shares of Merck worth $944K as of Q1 2026.
  • Ames National Corp sold 250 Merck shares in Q1 2026, an estimated $28.9K.
  • Merck made up 0.57% of Ames National Corp's portfolio in Q1 2026, its #31 holding.
  • Ames National Corp first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Ames National Corp's Merck position peaked at $969K in Q4 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ames National Corp's 13F filing for Q1 2026, filed 12 May 2026.